Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-07

FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for Potassium Chloride filed by Baxter Healthcare Corporation, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)